GCTK Form 3: Director Brendel Victoria Carr Reports Zero Holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Glucotrack, Inc. (GCTK) Form 3 shows that Brendel Victoria Carr is listed as a director and filed an initial Section 16 disclosure for the 05/22/2025 event date. The filing states no securities are beneficially owned by the reporting person and includes an exhibit appointing a power of attorney for signature. This indicates the director currently holds no equity position disclosed under Section 16.
Positive
- Director identified as Brendel Victoria Carr, fulfilling disclosure duty
- No securities beneficially owned reported as of 05/22/2025, removing short‑term insider trading signals
Negative
- Director holds no equity, which may limit alignment with shareholders
FAQ
What does the Glucotrack (GCTK) Form 3 disclose about the reporting person?
The Form 3 lists Brendel Victoria Carr as a director and indicates no securities are beneficially owned as of the reported event date.
When is the event date reported on the Glucotrack Form 3 (GCTK)?
The event date reported on the Form 3 is 05/22/2025.
Does the Form 3 show any derivative or non‑derivative holdings for the reporting person?
No. The filing explicitly states no securities are beneficially owned and lists no derivative or non‑derivative holdings.
Was a power of attorney included with the Form 3 for Glucotrack (GCTK)?
Yes. The filing includes an exhibit list noting Exhibit 24 – Power of Attorney.
Is this Form 3 a joint filing or filed by one reporting person for GCTK?
The form is indicated as filed by one reporting person.